A detailed history of Fort Washington Investment Advisors Inc transactions in Novartis Ag stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 33,925 shares of NVS stock, worth $3.63 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
33,925
Previous 34,625 2.02%
Holding current value
$3.63 Million
Previous $3.69 Million 5.86%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$106.13 - $120.89 $74,291 - $84,623
-700 Reduced 2.02%
33,925 $3.9 Million
Q2 2024

Jul 30, 2024

SELL
$92.57 - $107.37 $5.62 Million - $6.52 Million
-60,692 Reduced 63.67%
34,625 $3.69 Million
Q1 2024

May 13, 2024

SELL
$95.27 - $108.47 $52,398 - $59,658
-550 Reduced 0.57%
95,317 $9.22 Million
Q4 2023

Jan 17, 2024

SELL
$92.27 - $101.54 $21,314 - $23,455
-231 Reduced 0.24%
95,867 $9.68 Million
Q3 2023

Nov 07, 2023

SELL
$94.73 - $105.13 $102,687 - $113,960
-1,084 Reduced 1.12%
96,098 $9.79 Million
Q2 2023

Jul 28, 2023

SELL
$92.52 - $104.91 $36,637 - $41,544
-396 Reduced 0.41%
97,182 $9.81 Million
Q4 2022

Jan 30, 2023

SELL
$75.55 - $92.52 $39,437 - $48,295
-522 Reduced 0.53%
97,578 $8.85 Million
Q3 2022

Oct 26, 2022

SELL
$74.61 - $87.26 $187,569 - $219,371
-2,514 Reduced 2.5%
98,100 $7.46 Million
Q2 2022

Aug 05, 2022

SELL
$80.52 - $93.75 $197,274 - $229,687
-2,450 Reduced 2.38%
100,614 $8.51 Million
Q1 2022

May 03, 2022

SELL
$80.11 - $90.62 $8,011 - $9,062
-100 Reduced 0.1%
103,064 $9.04 Million
Q4 2021

Feb 07, 2022

SELL
$79.7 - $88.13 $411,172 - $454,662
-5,159 Reduced 4.76%
103,164 $9.02 Million
Q3 2021

Nov 09, 2021

SELL
$81.78 - $95.14 $24,534 - $28,542
-300 Reduced 0.28%
108,323 $8.86 Million
Q2 2021

Aug 09, 2021

SELL
$85.24 - $94.15 $180,708 - $199,598
-2,120 Reduced 1.91%
108,623 $9.91 Million
Q1 2021

May 05, 2021

SELL
$83.5 - $98.47 $308,950 - $364,339
-3,700 Reduced 3.23%
110,743 $9.47 Million
Q4 2020

Feb 03, 2021

SELL
$78.07 - $94.43 $67,920 - $82,154
-870 Reduced 0.75%
114,443 $10.8 Million
Q3 2020

Nov 10, 2020

SELL
$82.14 - $91.0 $2.36 Million - $2.61 Million
-28,693 Reduced 19.92%
115,313 $10 Million
Q2 2020

Jul 31, 2020

SELL
$80.93 - $91.1 $57.1 Million - $64.3 Million
-705,355 Reduced 83.05%
144,006 $12.6 Million
Q1 2020

May 06, 2020

BUY
$70.67 - $99.01 $5.93 Million - $8.31 Million
83,921 Added 10.96%
849,361 $70 Million
Q4 2019

Feb 03, 2020

SELL
$84.35 - $95.37 $23.7 Million - $26.8 Million
-281,498 Reduced 26.89%
765,440 $72.5 Million
Q3 2019

Nov 08, 2019

SELL
$85.54 - $94.26 $31.7 Million - $34.9 Million
-370,777 Reduced 26.15%
1,046,938 $91 Million
Q2 2019

Aug 12, 2019

SELL
$75.4 - $92.8 $11.7 Million - $14.4 Million
-155,136 Reduced 9.86%
1,417,715 $129 Million
Q1 2019

May 10, 2019

SELL
$75.32 - $86.15 $28.1 Million - $32.1 Million
-372,968 Reduced 19.17%
1,572,851 $151 Million
Q4 2018

Feb 05, 2019

SELL
$73.66 - $82.02 $5.48 Million - $6.1 Million
-74,366 Reduced 3.68%
1,945,819 $167 Million
Q3 2018

Nov 07, 2018

BUY
$66.94 - $77.43 $769,140 - $889,670
11,490 Added 0.57%
2,020,185 $174 Million
Q2 2018

Jul 27, 2018

BUY
$64.91 - $73.36 $14.9 Million - $16.8 Million
229,048 Added 12.87%
2,008,695 $152 Million
Q1 2018

May 02, 2018

BUY
$70.39 - $84.15 $1.06 Million - $1.27 Million
15,040 Added 0.85%
1,779,647 $144 Million
Q4 2017

Feb 12, 2018

BUY
$72.33 - $77.64 $6.8 Million - $7.3 Million
93,988 Added 5.63%
1,764,607 $148 Million
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $354,537 - $369,505
4,782 Added 0.29%
1,670,619 $143 Million
Q2 2017

Aug 10, 2017

BUY
N/A
1,665,837
1,665,837 $139 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $230B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fort Washington Investment Advisors Inc Portfolio

Follow Fort Washington Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.